Kessler Foundation
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Kessler Foundation sits in the top decile of US sponsors by registered trial count (#234 of 15,742 sponsors by registered trial count).
Kessler Foundation: 104 sponsored US clinical trials, 34 recruiting.
Kessler Foundation sponsors 104 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 58 completed. 0 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
Kessler Foundation ranks in the top decile of sponsors by registered trial count (#234 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
58 of 59 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
104 total, page 3 of 3
A Pilot Study Investigating the Feasibility of the Saebo Arm Training Program on an Inpatient Population
NCT00489580
Saeboflex Dynamic Hand Orthosis for Inpatient Rehabilitation Stroke Patients
NCT00485641
Improving New Learning and Memory in Multiple Sclerosis
NCT00166283
Modafinil in Multiple Sclerosis
NCT00142402
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 4 |
What is open in the Kessler Foundation pipeline
34 recruiting of 104 indexed (33% open); 58 completed (56%).
Phase mix: 0 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kessler Foundation: open-pipeline peers nationwide
Peers matched on 104 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Kessler Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 104 trials (± recruiting share)
- Boston University Charles River Campus · 104 trials · 22% recruiting
- Virginia Polytechnic Institute and State University · 104 trials · 17% recruiting
- Butler Hospital · 103 trials · 9% recruiting
- Augusta University · 106 trials · 12% recruiting
Sponsors near 33% open enrollment (± trial volume)
- University of Nevada, Las Vegas · 33% recruiting · 52 trials
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
Related
What to do with this Kessler Foundation page
104 registered trials is a research-attention snapshot, not an endorsement of Kessler Foundation or any single study.
- 34 of Kessler Foundation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition Kessler Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Kessler Foundation pipeline card: 104 registered trials from official public datasets.Report a data error.